• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,913.50 -582.86
( -0.75%)
Global Indices
Nasdaq
49,530.46 -142.69
(-0.29%)
Dow Jones
7,252.74 22.73
(0.31%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,375.34 -3.48
(-0.03%)
Forex
USD-INR
94.96 0.17
(0.17%)
EUR-INR
111.11 0.25
(0.23%)
GBP-INR
128.48 0.55
(0.43%)
JPY-INR
0.60 0.01
(1.28%)

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524636
INE102E01018
-9.9177201
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
200.97
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Refex Industries rises after securing order worth Rs 49 crore
Feb 17,2026
The contract pertains to material handling and transit operations for bulk commodity material. The order has been awarded by a domestic entity and will be executed over a period of three years. The company clarified that neither the promoter nor the promoter group has any interest in the awarding entity. Further, the contract does not fall under related party transactions.

Chennai-based Refex Industries has built a portfolio spanning ash and coal handling, wind energy, and green mobility solutions.

The company reported consolidated net profit rose 5.03% to Rs 61.34 crore despite a 16.04% drop in revenue from operations to Rs 576.01 crore in Q3 FY26 over Q3 FY25.